TIAA CREF Investment Management’s ChemoCentryx, Inc. CCXI Stock Holding History

TIAA CREF Investment Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$4.01M	Sell	288,597 -22,894	-7%	-$262K	﹤0.01%	1587
2018 Q4	$3.4M	Sell	311,491 -19,845	-6%	-$209K	﹤0.01%	1619
2018 Q3	$4.19M	Sell	331,336 -34,407	-9%	-$415K	﹤0.01%	1690
2018 Q2	$4.82M	Buy	365,743 +154,317	+73%	+$1.85M	﹤0.01%	1626
2018 Q1	$2.88M	Buy	211,426 +90,294	+75%	+$932K	﹤0.01%	1902
2017 Q4	$721K	Buy	121,132 +11,124	+10%	+$76.3K	﹤0.01%	2624
2017 Q3	$816K	Hold	110,008	–	–	﹤0.01%	2620
2017 Q2	$1.03M	Sell	110,008 -18,538	-14%	-$136K	﹤0.01%	2530
2017 Q1	$936K	Buy	128,546 +35,049	+37%	+$252K	﹤0.01%	2541
2016 Q4	$692K	Buy	93,497 +29,432	+46%	+$212K	﹤0.01%	2707
2016 Q3	$387	Sell	64,065 -3,006	-4%	-$14.2K	﹤0.01%	2944
2016 Q2	$301K	Sell	67,071 -32,532	-33%	-$122K	﹤0.01%	3033
2016 Q1	$248K	Hold	99,603	–	–	﹤0.01%	2948
2015 Q4	$807K	Hold	99,603	–	–	﹤0.01%	2705
2015 Q3	$603K	Hold	99,603	–	–	﹤0.01%	2830
2015 Q2	$820K	Sell	99,603 -20,600	-17%	-$164K	﹤0.01%	2794
2015 Q1	$908K	Sell	120,203 -3,917	-3%	-$30.6K	﹤0.01%	2672
2014 Q4	$848K	Buy	124,120 +6,771	+6%	+$35.8K	﹤0.01%	2744
2014 Q3	$528K	Sell	117,349 -5,158	-4%	-$27.3K	﹤0.01%	2952
2014 Q2	$717K	Buy	122,507 +24,731	+25%	+$139K	﹤0.01%	2906
2014 Q1	$648K	Sell	97,776 -32,979	-25%	-$229K	﹤0.01%	2863
2013 Q4	$757K	Hold	130,755	–	–	﹤0.01%	2818
2013 Q3	$727K	Buy	130,755 +9,162	+8%	+$99.1K	﹤0.01%	2807
2013 Q2	$1.72M	Buy	+121,593	New	+$1.58M	﹤0.01%	2262

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TIAA CREF Investment Management's CCXI Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its ChemoCentryx, Inc. (CCXI) stake by 7.3% in Q1 2019, selling an estimated $262K and leaving 288,597 shares worth $4.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1587.

TIAA CREF Investment Management first reported a position in CCXI in Q2 2013 and has held it in 24 quarters since. The position peaked at $4.82M in Q2 2018. 117 funds tracked by Wall St. Rank hold CCXI as of Q1 2019.

TIAA CREF Investment Management held 288,597 shares of ChemoCentryx, Inc. worth $4.01M as of Q1 2019.
TIAA CREF Investment Management sold 22,894 ChemoCentryx, Inc. shares in Q1 2019, an estimated $262K.
ChemoCentryx, Inc. made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1587 holding.
TIAA CREF Investment Management first reported a position in ChemoCentryx, Inc. in Q2 2013 and has held it in 24 quarters since.
TIAA CREF Investment Management's ChemoCentryx, Inc. position peaked at $4.82M in Q2 2018.
117 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.